[SUNZEN] Independent Director APPOINTMENT - DR FONG CHAN SENG on 04-Feb-2020

Announcement Date
04-Feb-2020
Board Member Information:
Date of Change
30-May-2019
Type of Change
APPOINTMENT
Designation
Independent Director
Directorate
Independent and Non Executive
Age
72
Gender
Male
Nationality
Malaysia
Working Experience
Dr Fong has thirty seven (37) years of industry experience. He held several job portfolios during his employment with Pfizer - Malaysia. Dr Fong joined Pfizer as Veterinary Promotions Manager in 1981. Throughout seven (7) years of serving the domestic market in Malaysia, he held positions as Product Manager, National Sales Manager and Feedmill Marketing Manager. Dr Fong was posted to Thailand as the Business Manager of Pfizer Thailand Ltd for three (3) years from 1988 to 1990. His responsibilities included running the animal health business of Pfizer Thailand, and a premix plant, product formulation, product quality control, and development of product stability. He was promoted to the position of Regional Director of Sales for Association of South East Asia Nation (ASEAN) countries in 1991. He was also in charge of business development for Pfizer in China, Hong Kong and Sri Lanka. When Pfizer acquired the worldwide animal health business of SmithKline Beecham, he was specifically in charge of the acquisition and problem solving activities in the Philippines from 1994 to 1996.

In 1998, Dr Fong together with the existing management of Pfizer in Malaysia, established Sunzen Corporation Sdn. Bhd. ("Sunzen Corporation") to undertake a management buy-out of Pfizers local distribution and marketing operations. In 2001, Dr Fong left Sunzen Corporation to join Phibro Animal Health Inc, USA as Regional Director for ASEAN countries and as Managing Director of their local incorporated company, Phibro Malaysia Sdn Bhd. He rejoined Sunzen Corporation in 2002 and appointed as an Executive Director of Sunzen Biotech Berhad on 25 April 2008 and subsequently resigned on 18 July 2014.
Directorship of Public Companies
Nil
Family Relationship
Nil
Conflict of Interest
Nil
Interest
Direct - 31,290 Ordinary Shares in the Company
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment